High levels of SET have been detected in a number of different human malignancies, including cancers from uterus, colon, stomach, and rectum [29], ovarian tumor [34], Wilms' tumor and leukemia [35], [36], thus implying an oncogenic role of SET in tumorigenesis. Here, SET is linked to ovarian neoplasm.